Clinical trials in Ceccano

2 clinical trials in Ceccano, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Ceccano at a glance

clinical trials

Recruiting now0
Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

2 trials in Ceccano

Open in trial search

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

Registered drugNo placebo

Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Ceccano

What the registry says about research in the country

01 Diabetes Research

Innovative clinical trials focusing on Type 2 diabetes management are evaluating advanced treatment options. The research examines a novel weekly combination therapy against traditional daily insulin treatments for better glycemic control.

Blood Sugar Management
Insulin Therapy Innovation
Treatment Optimization

These studies aim to enhance treatment convenience and effectiveness for patients managing long-term diabetes care through the exploration of weekly medication administration compared to daily insulin regimens.

Back to Italy All countries